Company Filing History:
Years Active: 2002-2006
Title: The Innovations of Brenda J Dean in Cell-Based Delivery Technology
Introduction
Brenda J Dean, an innovative inventor based in Cumberland, RI, has made significant contributions to the field of cell-based delivery technology. With two patents to her name, she has dedicated her career to advancing medical technologies that enhance treatment methodologies.
Latest Patents
One of Brenda's significant inventions is the ARPE-19 platform cell line for encapsulated cell-based delivery. This innovative technology involves ARPE-19 cells, which were evaluated as a robust platform for both encapsulated and unencapsulated cell delivery systems. These cells exhibit exceptional viability in stringent environments, including the central nervous system and intra-ocular settings. The ARPE-19 cell line can be genetically modified to secrete desired proteins, possesses a long lifespan, and is of human origin. Notably, they demonstrate excellent in vivo device viability, deliver an effective quantity of growth factors, induce minimal host immune reactions, and are non-tumorigenic.
Career Highlights
Brenda's work at Neurotech S.A. showcases her commitment to innovation in medical technology. Her focus on cell-based delivery systems highlights her role in advancing therapeutic options for patients, especially in complex medical scenarios that require precision and efficacy.
Collaborations
Throughout her career, Brenda has collaborated with notable colleagues, including Weng Tao and David H Rein. These partnerships have contributed to the development of her groundbreaking patents and have fostered an environment of collaborative innovation within their field.
Conclusion
Brenda J Dean’s contributions as an inventor are a testament to her pioneering spirit in scientific research and technological advancement. Her innovative work on the ARPE-19 cell line positions her as a key figure in the future of access to effective cell-based therapies. Her achievements inspire both current and future generations of inventors and researchers in the field of cell-based medicine.